News + Filings Transactions
|
Adjuvant Global Health Technology Fund, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 4.8k | $16.07 | $76.7k | | 09/29/2023 |
| 10/02/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 902 | $16.07 | $14.5k | By Adjuvant Global Health Technology Fund DE, L.P. | 09/29/2023 |
| 09/29/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 83.3k | $16.28 | $1.4M | | 09/29/2023 |
| 09/29/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 15.8k | $16.28 | $256.6k | By Adjuvant Global Health Technology Fund DE, L.P. | 09/29/2023 |
| 09/28/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 7.2k | $16.11 | $115.3k | | 09/27/2023 |
| 09/28/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 1.4k | $16.11 | $21.8k | By Adjuvant Global Health Technology Fund DE, L.P | 09/27/2023 |
| 09/27/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 707 | $16.07 | $11.4k | | 09/27/2023 |
| 09/27/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 134 | $16.07 | $2.2k | By Adjuvant Global Health Technology Fund DE, L.P | 09/27/2023 |
| 08/23/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 64 | $16.00 | $1k | By Adjuvant Global Health Technology Fund DE, L.P. | 08/23/2023 |
| 08/23/2023 | AN2 Therapeutics, Inc. | | Sale | Common Stock | 336 | $16.00 | $5.4k | | 08/23/2023 |
| 06/06/2022 | AN2 Therapeutics, Inc. | | Other (disposition) | Common Stock | 26.5k | $15.00 | $397.7k | | 06/06/2022 |
| 06/06/2022 | AN2 Therapeutics, Inc. | | Other (acquisition) | Common Stock | 26.5k | $15.00 | $397.7k | By Adjuvant Global Health Technology Fund DE, L.P. | 06/06/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 74.2k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 392.4k | $0.00 | $0 | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 312.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 1.7M | $0.00 | $0 | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Purchase | Common Stock | 166.7k | $15.00 | $2.5M | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 74.2k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 392.4k | $0.00 | $0 | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 312.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 1.7M | $0.00 | $0 | | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 312.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 392.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 74.2k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Purchase | Common Stock | 166.7k | $15.00 | $2.5M | By Adjuvant Global Health Technology Fund, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 1.7M | $0.00 | $0 | By Adjuvant Global Health Technology Fund, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 312.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 392.4k | $0.00 | $0 | By Adjuvant Global Health Technology Fund, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 74.2k | $0.00 | $0 | By Adjuvant Global Health Technology Fund DE, L.P. | 03/29/2022 |
| 03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 1.7M | $0.00 | $0 | By Adjuvant Global Health Technology Fund, L.P. | 03/29/2022 |
|